|
|
Line 1: |
Line 1: |
| [[Image:Acute leukemia-ALL.jpg | thumb|right|A bone marrow of an individual with precursor B-cell lymphoblastic leukemia. [[Wright stain]]. (WC)]] | | [[Image:Acute leukemia-ALL.jpg | thumb|right|A bone marrow of an individual with precursor B-cell lymphoblastic leukemia. [[Wright stain]]. (WC)]] |
| The article addresses '''leukemia''', which is uncommonly seen by anatomical pathologists. It is a subset of [[hematopathology]]. | | The term '''leukemia''' is broadly used to refer to any haematological malignancy where the neoplastic cells in the circulation are the prominent feature. It is generally only seen by anatomical pathologists only in countries where hematopathology reporting is done by anatomical pathologists rather than hematologists. |
|
| |
|
| Lymphoma is discussed in the ''[[lymphoma]]'' article, and overlaps somewhat with leukemia as the clear distinction between the two is historical (see below). | | Lymphoma is discussed in the ''[[lymphoma]]'' article, and overlaps somewhat with leukemia as the clear distinction between the two is somewhat arbitrary and historical:<ref>{{Ref PCPBoD8|314}}</ref> |
| | |
| Historical classification:<ref>{{Ref PCPBoD8|314}}</ref>
| |
| *Leukemia = involves bone marrow +/- peripheral blood. | | *Leukemia = involves bone marrow +/- peripheral blood. |
| **Classic presentation: infection, bleeding, anemia. | | **Classic presentation: infection, bleeding, anemia. |
Line 11: |
Line 9: |
|
| |
|
| =Definition= | | =Definition= |
| All of the following:<ref name=dg21mar20011>D. Good. 21 March 2011.</ref>
| | This varies with the type. |
| | |
| | For acute myeloid leukemia, all of the following:<ref name=dg21mar20011>D. Good. 21 March 2011.</ref> |
| #Morphologic abnormalities. | | #Morphologic abnormalities. |
| #>20% blasts ''or'' recurrent cytogenetic abnormality. | | #>20% blasts ''or'' recurrent cytogenetic abnormality. |
Line 19: |
Line 19: |
| *inv(16). | | *inv(16). |
| *t(15;17). | | *t(15;17). |
| | |
| | =Leukemia classification= |
| | *[[Acute myeloid leukemia]] (AML): |
| | *#AML. |
| | *#AML with recurrent cytogenetic abnormalities. |
| | *#AML from [[MDS]]. |
| | *#AML in the setting of [[Down syndrome]]. |
| | |
| | *[[Acute lymphoblastic leukemia]] (ALL): |
| | *#B cell. |
| | *#B cell with recurrent cytogenetic abnormalities. |
| | *#T cell (sometimes abbreviated to T-ALL) |
| | |
| | *Not to be confused with [[adult T-cell leukemia/lymphoma]] (ATLL) |
| | |
| | *[[Chronic myeloid leukemia]] (CML) |
| | *[[Chronic lymphocytic leukemia]] (CLL) - usually classified with lymphomas |
| | |
| | Rarer leukemias: |
| | *Plasma cell leukaemia |
| | *Mast cell leukemia |
|
| |
|
| =Histomorphologic overview= | | =Histomorphologic overview= |
Line 38: |
Line 59: |
| |} | | |} |
| † should be easy to remember as smALL people, i.e. kids, get this type of acute leukemia. | | † should be easy to remember as smALL people, i.e. kids, get this type of acute leukemia. |
|
| |
|
| |
|
| =Algorithms= | | =Algorithms= |
Line 49: |
Line 69: |
| *[[Down syndrome]]? | | *[[Down syndrome]]? |
|
| |
|
| =Leukemia classification=
| |
| Acute myeloid leukemia (AML):
| |
| #AML.
| |
| #AML with recurrent cytogenetic abnormalities.
| |
| #AML from [[MDS]].
| |
| #AML in the setting of [[Down syndrome]].
| |
|
| |
| Acute lymphoid leukemia (ALL):
| |
| #B cell.
| |
| #B cell with recurrent cytogenetic abnormalities.
| |
| #T cell.
| |
|
| |
| Chronic myeloid leukemia (CML).
| |
|
| |
|
| =Prognosis= | | =Prognosis= |
Line 70: |
Line 77: |
|
| |
|
| =Specific diagnoses= | | =Specific diagnoses= |
| ==Acute myeloid leukemia==
| | *[[Acute myeloid leukemia]] |
| *Abbreviated ''[[AML]]''.
| | *[[Acute lymphoblastic leukemia]] |
| ===General===
| | *[[Chronic myeloid leukemia]] |
| *Adults.
| | *[[Chronic lymphocytic leukemia]] |
| | |
| Exclusions for this diagnosis:
| |
| *Prior [[MDS]].
| |
| *[[Down syndrome]].
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *[[Auer rods]] present | |
| *Cytoplasmic granularity.
| |
| *Large cells.
| |
| | |
| Note:
| |
| *May be classified by morphology, using the (old) French-American-British (FAB) classification (M0-M7).
| |
| | |
| ====Image====
| |
| <gallery>
| |
| Image:Auer_rods.PNG | Auer rods in an AML. (WC)
| |
| </gallery>
| |
| www:
| |
| *[http://path.upmc.edu/cases/case344.html AML - several images (upmc.edu)].
| |
| | |
| ===Molecular===
| |
| *Must exclude all the recurrent cytogenetic abnormalities - see below.
| |
| | |
| ==AML with recurrent cytogenetic abnormalities==
| |
| ===Acute myeloid leukemia with t(8;21)===
| |
| *t(8;21)(q22;q22).<ref>{{Cite journal | last1 = Berger | first1 = R. | title = Translocation t(8;21)(q22;q22): cytogenetics and molecular biology. | journal = Nouv Rev Fr Hematol | volume = 36 Suppl 1 | issue = | pages = S67-9 | month = | year = 1994 | doi = | PMID = 8177719 }}</ref>
| |
| | |
| IHC:
| |
| *CD34+, CD13+, MPO+ (cytoplasm), CD33+ (weak).
| |
| *[[CD56]]+, CD117+.
| |
| **Usu. assoc. with a bad prognosis.
| |
| | |
| Flow cytometry:
| |
| *CD19+, PAX5+, CD79a +/-.
| |
| | |
| Images:
| |
| *[http://path.upmc.edu/cases/case712.html AML with t(8;21) (upmc.edu)]. | |
| | |
| ===Acute myeloid leukemia with inv(16)===
| |
| *inv(16)(p13.1q22).<ref name=pmid16917916>{{Cite journal | last1 = Lu | first1 = CM. | last2 = Murata-Collins | first2 = JL. | last3 = Wang | first3 = E. | last4 = Siddiqi | first4 = I. | last5 = Lawrence | first5 = HJ. | title = Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases. | journal = Am J Hematol | volume = 81 | issue = 12 | pages = 963-8 | month = Dec | year = 2006 | doi = 10.1002/ajh.20716 | PMID = 16917916 }}
| |
| </ref>
| |
| | |
| *Associated with [[myeloid sarcoma]].
| |
| | |
| Microscopic:
| |
| *Blast count usu. ~20% (low).
| |
| *Eosinophilic granules.
| |
| **Used to be classified as "M4" with eosinophilia.
| |
| | |
| IHC:
| |
| *CD2+ -- common.
| |
| | |
| ===Acute myeloid leukemia with t(15;17)===
| |
| *[[AKA]] ''acute promyelocytic leukemia'' | |
| **Abbreviated ''APL''.
| |
| *t(15;17)(q22;q12).
| |
| **Fusion transcripts: PML<ref name=omim102578>{{OMIM|102578}}</ref>-RARA.<ref name=omim180240>{{OMIM|180240}}</ref>
| |
| | |
| ====General====
| |
| Clinical:
| |
| *Associated with [[DIC]].
| |
| *Treatment: all-trans retinoic acid (ATRA).
| |
| | |
| Variants:
| |
| *t(11;17) -- ATRA doesn't work.<ref>{{Ref APBR|623 Q2}}</ref>
| |
| *t(17;17) -- ATRA doesn't work.
| |
| *t(5;17). (???)
| |
| | |
| ====Microscopic====
| |
| Comes in two flavours.
| |
| | |
| Microscopic (Hypergranular ''or'' typical APL):
| |
| *Bean-shaped nucleus ''or'' bilobed nucleus.
| |
| *Buddles of Auer rods - known as "Faggot cells".
| |
| | |
| Microscopic (Microgranular ''or'' hypogranular APL):
| |
| *Bilobed nuclei with nuclear overlap. (???)
| |
| *Absence of granules on light microscopy.
| |
| | |
| =====Images=====
| |
| <gallery>
| |
| Image:Faggot cell in AML-M3.jpg |Faggot cell in AML-M3. (WC)
| |
| </gallery>
| |
| www:
| |
| *[http://path.upmc.edu/cases/case457/images/fig01.jpg AML - showing Auer rods (upmc.edu)].<ref>URL: [http://path.upmc.edu/cases/case457.html http://path.upmc.edu/cases/case457.html]. Accessed on: 21 January 2012.</ref> | |
| *[http://path.upmc.edu/cases/case705.html APML - several images (upmc.edu)].
| |
| | |
| ====IHC====
| |
| *CD2 +ve, CD34 +ve/-ve, CD56 +ve/-ve.
| |
| | |
| ====[[Flow cytometry]]====
| |
| *CD34 -ve, HLA-DR -ve.
| |
| *CD33 +ve, CD13 +ve/-ve, CD117 +ve (weak), CD56 +ve/-ve.
| |
| | |
| ===Acute myeloid leukemia with t(9;11)===
| |
| *t(9;11).
| |
| | |
| Microscopic:
| |
| *Monoblastic morphology. (???)
| |
| *Myelomonocytic morphology. (???)
| |
| | |
| Clinical:
| |
| *+/-[[DIC]].
| |
| *Usu. children.
| |
| | |
| IHC:
| |
| *CD33+, CD65+, CD4+, HLA-DR+.
| |
| *CD34+. (???)
| |
| *CD13+. (???)
| |
| | |
| ==Chronic myeloid leukemia==
| |
| {{:Chronic myeloid leukemia}}
| |
|
| |
|
| =See also= | | =See also= |